According to filings with the U.S. Securities and Exchange Commission, OLC Development, Inc. dba OrthoLazer is raising up to $10,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About OLC Development, Inc. dba OrthoLazer
OrthoLazer Orthopedic Laser Centers offer both patients and their orthopedic doctors an innovative and effective alternative pain management option to treat acute and chronic orthopedic conditions. Founded by Dr. Scott Sigman the original opioid-sparing surgeon these centers further his mission of providing his patients non-operative and non-opioid treatment options. The overwhelming patient response to his first OrthoLazer Center led to the new initiative to make OrthoLazer Centers available to patients nationwide. OrthoLazer Orthopedic Laser Centers are powered by the exclusive MLS M8 Robotic Laser. This FDA-cleared and patented technology treats the pain and inflammation associated with a wide variety of soft tissue injuries, nerve pain, arthritis and surgery with no known side effects. Additionally, the MLS M8 Robotic Laser is the only high-powered laser that is non-invasive, painless, and completely free of the side effects and risks associated with other lasers used in the market today.

To learn more about OLC Development, Inc. dba OrthoLazer, visit https://ortholazer.com/
OLC Development, Inc. dba OrthoLazer Linkedin Page: https://www.linkedin.com/company/ortholazer/

Contact:
Kenneth Hancock, Chief Executive Officer
888-652-9199

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.